GB9827393D0 - Treatment of erectile dysfunction in diabetes patients - Google Patents

Treatment of erectile dysfunction in diabetes patients

Info

Publication number
GB9827393D0
GB9827393D0 GBGB9827393.1A GB9827393A GB9827393D0 GB 9827393 D0 GB9827393 D0 GB 9827393D0 GB 9827393 A GB9827393 A GB 9827393A GB 9827393 D0 GB9827393 D0 GB 9827393D0
Authority
GB
United Kingdom
Prior art keywords
treatment
erectile dysfunction
diabetes patients
diabetes
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9827393.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Priority to GBGB9827393.1A priority Critical patent/GB9827393D0/en
Publication of GB9827393D0 publication Critical patent/GB9827393D0/en
Priority to EP99959520A priority patent/EP1137460A2/en
Priority to PCT/GB1999/004095 priority patent/WO2000035431A2/en
Priority to AU16664/00A priority patent/AU1666400A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9827393.1A 1998-12-11 1998-12-11 Treatment of erectile dysfunction in diabetes patients Ceased GB9827393D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9827393.1A GB9827393D0 (en) 1998-12-11 1998-12-11 Treatment of erectile dysfunction in diabetes patients
EP99959520A EP1137460A2 (en) 1998-12-11 1999-12-06 Treatment of erectile dysfunction in diabetes patients
PCT/GB1999/004095 WO2000035431A2 (en) 1998-12-11 1999-12-06 Treatment of erectile dysfunction in diabetes patients
AU16664/00A AU1666400A (en) 1998-12-11 1999-12-06 Treatment of erectile dysfunction in diabetes patients

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9827393.1A GB9827393D0 (en) 1998-12-11 1998-12-11 Treatment of erectile dysfunction in diabetes patients

Publications (1)

Publication Number Publication Date
GB9827393D0 true GB9827393D0 (en) 1999-02-03

Family

ID=10844117

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9827393.1A Ceased GB9827393D0 (en) 1998-12-11 1998-12-11 Treatment of erectile dysfunction in diabetes patients

Country Status (4)

Country Link
EP (1) EP1137460A2 (en)
AU (1) AU1666400A (en)
GB (1) GB9827393D0 (en)
WO (1) WO2000035431A2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5814650A (en) * 1992-09-28 1998-09-29 Lifegroup S.P.A. Biotin amides able to control glucidic metabolisms under dysmetabolic conditions and relative therapeutical compositions
US5439938A (en) * 1993-04-07 1995-08-08 The Johns Hopkins University Treatments for male sexual dysfunction
FR2753098B1 (en) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic PHARMACEUTICAL COMPOSITION COMPRISING AT LEAST ONE NO SYNTHASE INHIBITOR AND AT LEAST ONE TRAP FOR REACTIVE OXYGEN FORMS
WO1998013037A1 (en) * 1996-09-25 1998-04-02 The Regents Of The University Of California Methods of using agmatine to reduce intracellular polyamine levels and to inhibit inducible nitric oxide synthase
US5916569A (en) * 1997-03-26 1999-06-29 E. Martin Spencer Human erectile dysfunction and methods of treatment
AU7575298A (en) * 1997-05-14 1998-12-08 Redox, Inc. Use of d-arginine and/or l-arginine to protect the amino groups of biological substances from damage, inactivation, or modification by toxic carbonyls and/or dicarbonyls
EP1075475B1 (en) * 1998-05-04 2003-06-18 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production

Also Published As

Publication number Publication date
EP1137460A2 (en) 2001-10-04
AU1666400A (en) 2000-07-03
WO2000035431A2 (en) 2000-06-22
WO2000035431A3 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
IL187512A0 (en) Use of (s,s)-reboxetine in the treatment of pain conditions and incontinence
GB9608408D0 (en) Treatment of erectile dysfunction
GB9903841D0 (en) Diagnosis and treatment of cancer
PT1716853E (en) Treatment of cancers of the human body using et743
PL352333A1 (en) Dihydrobenzodiazepines and use of same in treatment of dislipidemia
EP1079764A4 (en) The treatment of sexual dysfunction in certain patient groups
HUP0201966A3 (en) Methods of treatment and drug screening methods
GB9917346D0 (en) Medicament for treating premature ejaculation
IL149200A0 (en) Peptides for treatment of erectile dysfunction
GB9827393D0 (en) Treatment of erectile dysfunction in diabetes patients
AU5425500A (en) Use of nicorandil in treatment of sexual dysfunctions or for enhancement of sexual functions in mammals including human mammals
IL150202A0 (en) Method and composition for the treatment of pain
GB9908059D0 (en) Diagnosis and treatment of diseases
GB9904252D0 (en) Composition for the treatment of pain
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT
IL150208A0 (en) Compound and method for the treatment of pain
AU2002300509A1 (en) The Treatment of Sexual Dysfunction in Certain Patient Groups
IL145242A0 (en) Treatment of hiatial hernia
GB9826603D0 (en) Device for treatment, especially putting in plaster, of patients limb
SI1047428T1 (en) Use of morpholinol for the treatment of sexual dysfunction
AU2984399A (en) Pge-1 containing lyopholized liposomes for use in the treatment of erectile dysfunction
GB9815149D0 (en) Treatment of diabetes
GB9812314D0 (en) Treatment of diabetes
GB9905307D0 (en) Therapy and use of compounds in therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)